表紙
市場調查報告書

重氫化製劑治療的市場策略

Deuterated Drugs Formulations Therapeutics Markets Strategies

出版商 Greystone Research Associates 商品編碼 539022
出版日期 內容資訊 英文
商品交期: 最快1-2個工作天內
價格
Back to Top
重氫化製劑治療的市場策略 Deuterated Drugs Formulations Therapeutics Markets Strategies
出版日期: 2017年08月07日內容資訊: 英文
簡介

本報告提供重氫化製劑治療的市場相關調查,受現在FDA的認證的,以及處於後期開發階段的重氫化製劑,特徵,上市的過程,及治療特徵,促進重氫化製劑開發的主要原因,重氫化製劑開發者的產品策略,目前市場規模及主要企業等相關分析。

摘要整理

重氫化製劑治療

  • 製劑設計技術
  • 藥物特徵
  • 給藥間隔的擴張
  • 治療藥的未滿足需求支援

主要的短期治療目標

  • 神經傳達物質的調整
  • 薄膜傳導
  • 激酶抑制劑
  • 抗發炎藥
  • 粒腺體功能控制
  • 抗腫瘤藥物

重氫化製劑:短期性的治療市場分析

  • 中國
  • 自體免疫疾病
  • 遺傳性疾病
  • 神經性疾病
  • 癌症
  • 眼科疾病

市場要素

  • 法規、認證
  • 臨床實驗 & end point
  • IP/專利要素
  • 防衛性的專利策略
  • 醫療經濟學

企業簡介

目錄
Product Code: DTR354K

Deuterated Drugs: Products, Pipelines, Strategies, Therapeutics and Markets is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug formulation developers, product designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for drugs that incorporate deuterium into the chemical structure of APIs to modify drug properties in vivo. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Deuterated Drugs - What You Will Learn

  • What deuterated drugs are currently FDA-approved or in late-stage development, what are their distinguishing properties, how are they marketed, and what are the therapeutic specifics?
  • What are the major factors driving the development of deuterated drugs?
  • What are the product strategies of deuterated drug developers?
  • What is the size of the deuterated drug market today, who are the active sector participants, and what will the market look like in 2024?
  • How important are formulator-developer-manufacturer relationships and what are the key alliances in the industry?
  • What are the significant economic, technology, and regulatory factors affecting the market for deuterated drugs?

Table of Contents

Executive Summary

  • Drug Therapy Market Dynamics
  • Market Segments and Indications
  • Competing Technologies
  • Market Drivers
  • Drug Re-positioning/Re-purposing
  • Extending Patent Life
  • Dosing Frequency & Patient Adherence
  • Competitive Landscape
  • Formulators/Developers
  • Marketers
  • Alliances
  • Acquisitions

Deuterated Drug Therapeutics

  • Formulation Technology
  • Drug Property Kinetics
  • Extending Dosing Intervals
  • Addressing Unmet Therapeutic Needs

Selected Near-term Therapeutic Targets

  • Neurotransmitter Regulation
  • Transmembrane Conductance
  • Kinase Inhibitors
  • Anti-inflammatory
  • Mitochondrial Function Modulation
  • Antineoplastic

Deuterated Drugs - Near-term Therapeutic Market Analysis

  • Addiction
  • Autoimmune Diseases
  • Hereditary
  • Neurology
  • Oncology
  • Ophthalmology

Market Factors

  • Regulations and Approvals
  • Clinical Trials & End Points
  • IP/Patent Factors
  • Defensive Patent Strategies
  • Healthcare Economics

Company Profiles

Back to Top